#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Liposarcoma metastatic Paroxysmal nocturnal haemoglobinuria Cervix carcinoma recurrent Mantle cell lymphoma Sickle cell anaemia Fallopian tube cancer Phaeochromocytoma Mantle cell lymphoma stage II Hairy cell leukaemia recurrent Measles Biliary cancer metastatic Haemophilia A without inhibitors Oesophageal adenocarcinoma stage III Retinopathy of prematurity PIK3CA-activated mutation More trials…

    Learn about Rare Diseases

    CADASIL Mantle cell lymphoma stage IV – Basic Information Cystic fibrosis lung – Treatment Gaucher’s disease type I – Treatment Gaucher’s disease type I – Life with Disease Osteosarcoma recurrent – Diagnostics Antisynthetase syndrome – Diagnostics Mantle cell lymphoma – Treatment Erdheim-Chester disease – Trials in Disease Marfan’s syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mitapivat Psilocybine Taxanes L-METHIONINE Divarasib Abc-23A-116 Vx-670 Clotrimazole ZAMPILIMAB FERUMOXTRAN-10 Enalapril Motixafortide Etrumadenant Omp66 Gilteritinib Netupitant Rucaparib Camlipixant Amifostine Thiol Transcon Il-2Β/Γ More therapies…

    Learn about Your Condition

    Gouty arthritis Klinefelter's syndrome Clostridium difficile colitis Inborn error of metabolism Alcohol abuse Osteoporosis postmenopausal Albright's disease Craniosynostosis Testicular germ cell cancer Respiratory tract infection Breast angiosarcoma Aicardi-Goutieres syndrome Laryngeal leukoplakia Chronic disease Eczema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Metabolic dysfunction-associated steatohepatitis

  • Study of Fecal Microbiota Capsules for Treating Non-Alcoholic Steatohepatitis in Patients

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Allogeneic Faecal Microbiota, Pooled
    Spain

  • Study on Empagliflozin for Patients with Non-Alcoholic Steatohepatitis (NASH)

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Metabolic dysfunction-associated steatohepatitis
    Investigated Drugs:
    • Empagliflozin
    Czechia

  • Study on Efinopegdutide for Adults with Compensated Cirrhosis Due to Metabolic Dysfunction-Associated Steatohepatitis

    Not recruiting

    2 1
    Investigated Drugs:
    • Efinopegdutide
    France Spain

  • Study on the Effectiveness and Safety of Lanifibranor for Adults with Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH) and Liver Fibrosis Stages F2/F3

    Not recruiting

    3 1
    Investigated Drugs:
    • Lanifibranor
    Belgium Bulgaria Czechia France Germany Hungary +5

  • Study of resmetirom (MGL-3196) in patients with Non-Alcoholic Steatohepatitis (NASH) to prevent liver damage and disease progression

    Not recruiting

    3 1
    Investigated Drugs:
    • Resmetirom
    Austria Belgium France Germany Hungary Italy +2

  • Study on the Effects of Semaglutide in Patients with Non-Alcoholic Steatohepatitis (NASH) and Fibrosis Stages 2 or 3

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Semaglutide
    Austria Belgium Bulgaria Croatia Czechia Denmark +12
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!